Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.Published in:Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-xBy:Chia-Chi Lin;Calvo, Emiliano;Papadopoulos, Kyriakos P.;Patnaik, Amita;Sarantopoulos, John;Mita, Alain C.;Preston, Glenn G.;Mita, Monica M.;Rodon, Jordi;Mays, Theresa;I.-Tien Yeh;O'Rourke, Pat;Takimoto, Chris H.;Dancey, Janet E.;Chen, Helen;Tolcher, Anthony W.Publication type:Article